Keyphrases
Nave
77%
Antipsychotics
77%
Healthy Controls
69%
Fractional Anisotropy
64%
White Matter
61%
Ultra-high Risk for Psychosis
58%
Partial Least Squares Correlation
48%
Cerebral White Matter
47%
Schizophrenia
43%
White Matter Microstructure
41%
Schizophrenic Patients
41%
Twin Study
38%
Schizophrenia Spectrum Disorders
38%
Heritability
38%
Cortical Structure
38%
Cortical Thickness
31%
Cognitive Function
29%
Group Differences
29%
Psychopathology
28%
Diffusion-weighted Imaging
26%
White Matter Changes
25%
Correlation Analysis
25%
First-episode Psychosis
25%
Radial Diffusivity
21%
Axial Diffusivity
21%
Superior Longitudinal Fasciculus
21%
Psychiatric Patients
19%
Non-pharmacological
19%
Cerebral Blood Flow
19%
Pseudo-continuous Arterial Spin Labeling (pCASL)
19%
Pharmacological Modulation
19%
Glutamate
19%
Non-pharmaceutical Interventions
19%
Randomized Clinical Trial
19%
Negative Symptoms
19%
Confounding Effect
19%
First Episode
19%
Receptor Antagonist
19%
Diffusion Tensor Imaging
19%
Clinical Correlation
19%
Cognitive Remediation
19%
Patients with Schizophrenia
19%
Multimodal Assessment
19%
Dopamine D2/3 Receptor
19%
Recreational Drug Use
19%
Multivariate Pattern Analysis
19%
Mean Curvature
19%
Antagonist Treatment
19%
Whole Brain
17%
3T Magnetic Resonance Imaging
16%
Neuroscience
Dementia Praecox
100%
Antipsychotic
77%
Fractional Anisotropy
75%
Schizophrenia Spectrum Disorder
38%
Cognitive Function
38%
Diffusion MRI
36%
Negative Syndrome
24%
Superior Longitudinal Fasciculus
21%
Arterial Spin Labeling
19%
Magnetization Transfer
19%
Glutamic Acid
19%
Receptor Antagonist
19%
Putamen
19%
Cognitive Disorders
17%
Neuroplasticity
16%
Substance Abuse
14%
Diffusion Tensor Imaging
14%
Thalamus
13%
Randomized Controlled Trial
12%
Magnetic Resonance Imaging
12%
Medial Lemniscus
11%
Frontal Lobe
9%
Working Memory
9%
Meta-Analysis
6%
Structural Equation Modeling
5%
